The Kable

The Kable

Friday Kable

💉 Valneva's Ixchiq the first approved chikungunya vaccine; Moderna, others leveraging mRNA magic; Takeda gets two FDA approvals

#469 | A breakthrough in RA research; Improved T-cell therapies; Coca-Cola safe to drink in Croatia

Ria's avatar
Vinod's avatar
Ria and Vinod
Nov 10, 2023
∙ Paid

Hello, and welcome back to your favourite life sciences newsletter for the last time this week. Climate-resilient health systems are making recurring appearances in today’s edition. Our first story is an African perspective on approaches to enhance climate-resilient and low-carbon health systems.

Developing countries like South Africa have been pushing b…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 The Kable · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture